Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Paraguay gets 1 lakh Covaxin doses from India

Ruchika Sharma30 March 2021 1:52 PM IST

Paraguay: Paraguay on Monday received a shipment of 1,00,000 doses of India's indigenously developed Covaxin vaccine."Paraguay receives 100,000 doses...

Bharat Biotech, Biovet, Sapigen Biologix ink pact with CSIR-IICT for novel platform technologies, vaccine candidates

Ruchika Sharma30 March 2021 1:34 PM IST

Hyderabad: Vaccine maker Bharat Biotech, Biovet and Sapigen Biologix on Monday signed a collaborative research agreement with CSIR-Indian...

Indian regulator nod for Sputnik V expected in next few weeks: Dr Reddys

Ruchika Sharma30 March 2021 1:28 PM IST

Observing that trials of the vaccine have been conducted in Russia, India, the UAE and others, Sapra said the vaccine demonstrated an efficacy of 91.6...

Biocon Pharma, Libbs Farmaceutica collaborate to launch generic formulations in Brazil

Ruchika Sharma30 March 2021 12:29 PM IST

Bengaluru: Biocon Ltd has recently announced a partnership between Biocon Pharma Limited, a wholly-owned subsidiary of Biocon Limited, and Libbs...

Serum Institute's Covovax anticipated launch by September, says CEO Adar Poonawalla

Ruchika Sharma29 March 2021 11:00 AM IST

New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of Covid-19 vaccine Covovax have begun in India and the...

TechInvention, Eubiologics collaborate to bring oral cholera vaccine to India

Ruchika Sharma29 March 2021 10:30 AM IST

New Delhi: TechInvention Lifecare has tied up with South Korea-based biopharmaceutical firm Eubiologics Co Ltd for bringing in oral cholera vaccine...

Bristol-Myers Squibb gets USFDA nod to multiple myeloma therapy

Ruchika Sharma29 March 2021 10:15 AM IST

New Delhi: The U.S. Food and Drug Administration has approved Bristol-Myers Squibb Co and bluebird bio Inc's multiple myeloma therapy, ide-cel,...

Janssen gets positive CHMP opinion for Ponvory for treating relapsing forms of multiple sclerosis in adults

Ruchika Sharma29 March 2021 10:00 AM IST

Belgium: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the European Medicines Agency's (EMA) Committee for...

GSK gets EMA panel recommendation to approve Benlysta for adult patients with active lupus nephritis

Ruchika Sharma29 March 2021 9:30 AM IST

UK: GlaxoSmithKline plc (GSK) has recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

Gilead Sciences application for breast cancer therapy gets EMA validation

Ruchika Sharma28 March 2021 11:00 AM IST

Foster City: Gilead Sciences has recently announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application...

GSK application to expand use of Nucala for COPD accepted for review by EMA

GSK, Vir Biotechnology submit EUA request to USFDA for VIR-7831 for early Covid-19 treatment

Ruchika Sharma28 March 2021 10:30 AM IST

London and San Francisco: GlaxoSmithKline plc and Vir Biotechnology, Inc. have recently announced the submission of an application to the U.S. Food...

China Sinopharm's 100 million doses of COVID-19 vaccines supplied globally

Ruchika Sharma28 March 2021 10:15 AM IST

Beijing: Two COVID-19 vaccines developed by subsidiaries of China National Pharmaceutical Group (Sinopharm) have hit a combined 100 million doses of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok